Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Lancet (London, England)|July 20, 1991
Serum iron and neuroleptic malignant syndromeP I Rosebush, M F MazurekJournal of Clinical Psychopharmacology|August 1, 1996
Catatonia after benzodiazepine withdrawalP I Rosebush, M F MazurekNeurology|March 17, 1999
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidoneP I Rosebush, M F MazurekThe American Journal of Psychiatry|May 1, 1996
Circadian pattern of acute, neuroleptic-induced dystonic reactionsM F Mazurek, P I RosebushThe British Journal of Psychiatry : the Journal of Mental Science|November 1, 1991
The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?P I Rosebush, T Stewart, M F MazurekThe Journal of Neuropsychiatry and Clinical Neurosciences|April 21, 1998
Neuropsychiatric aspects of the adult variant of Tay-Sachs diseaseG M MacQueen, P I Rosebush, M F MazurekThe Journal of Clinical Psychiatry|January 1, 1994
Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothersG S Gaind, P I Rosebush, M F MazurekNeuroscience|April 2, 1998
Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the ratA J Levinson, S Garside, P I Rosebush, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
The neuropsychiatry of adult-onset adrenoleukodystrophyP I Rosebush, S Garside, A J Levinson, et al.The Journal of Clinical Psychiatry|August 24, 1999
Late-onset adrenoleukodystrophy associated with long-standing psychiatric symptomsS Garside, P I Rosebush, A J Levinson, et al.Pageof 6